5Mandell GL, Bennett JE, Raphael D, eds. Principles and Practice of Infectious Diseases. 5th ed. Philadelphia, London: Churchill Livingstone,2000. 821-856,2299-2301.
6Gordon KA, Jones RN. SENTRY participant groups. Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America:comparison report to Europe and Latin America: results from the SENTRY antimicrobial surveillance program ( 2000 ). Diagn Microbiol Infect Dis.2003.45,295-301.
7Beidenbach D J, Moet G J, Jones RN. Pathogen occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY antimicrobial surveillance program( 1997-2000 ). Diag Microbial Infect Dis ,2004,50:59-69.
8Paterson DL, Rossi F, Baquero F,et al. In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 study for monitoring antimicrobial resistance trends (SMART). J Antimicrob Chemother,2005, 55: 965-973.
9Hoban DJ, Biedenbach DJ, Mutnick AH, et al. Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY antimicrobial surveillance study(2000). Diagn Microbiol Infect Dis,2003, 45:279-285.
10Streit J, Jones RN, Sader HS, et al. Assessment of pathogen occurrence and resistance profiles among infected patients in the intensive care unit : report from the SENTRY antimicrobial surveillance program ( North America, 2001 ). Int J Antimicrob Agents,2004, 24:111-118.
